399 related articles for article (PubMed ID: 20193534)
21. Pelvic Ewing sarcomas. Three-dimensional conformal vs. intensity-modulated radiotherapy.
Mounessi FS; Lehrich P; Haverkamp U; Willich N; Bölling T; Eich HT
Strahlenther Onkol; 2013 Apr; 189(4):308-14. PubMed ID: 23443613
[TBL] [Abstract][Full Text] [Related]
22. A comparative study of dose distribution of PBT, 3D-CRT and IMRT for pediatric brain tumors.
Takizawa D; Mizumoto M; Yamamoto T; Oshiro Y; Fukushima H; Fukushima T; Terunuma T; Okumura T; Tsuboi K; Sakurai H
Radiat Oncol; 2017 Feb; 12(1):40. PubMed ID: 28228150
[TBL] [Abstract][Full Text] [Related]
23. Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas.
Fuji H; Schneider U; Ishida Y; Konno M; Yamashita H; Kase Y; Murayama S; Onoe T; Ogawa H; Harada H; Asakura H; Nishimura T
Radiat Oncol; 2013 Nov; 8():255. PubMed ID: 24180282
[TBL] [Abstract][Full Text] [Related]
24. Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity.
Landry JC; Yang GY; Ting JY; Staley CA; Torres W; Esiashvili N; Davis LW
Med Dosim; 2002; 27(2):121-9. PubMed ID: 12074463
[TBL] [Abstract][Full Text] [Related]
25. 3D-conformal RT, fixed-field IMRT and RapidArc, which one is better for esophageal carcinoma treated with elective nodal irradiation.
Wang D; Yang Y; Zhu J; Li B; Chen J; Yin Y
Technol Cancer Res Treat; 2011 Oct; 10(5):487-94. PubMed ID: 21895033
[TBL] [Abstract][Full Text] [Related]
26. Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy.
Shiraishi Y; Xu C; Yang J; Komaki R; Lin SH
Radiother Oncol; 2017 Oct; 125(1):48-54. PubMed ID: 28917586
[TBL] [Abstract][Full Text] [Related]
27. Single-arc volumetric-modulated arc therapy (sVMAT) as adjuvant treatment for gastric cancer: dosimetric comparisons with three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT).
Wang X; Li G; Zhang Y; Bai S; Xu F; Wei Y; Gong Y
Med Dosim; 2013; 38(4):395-400. PubMed ID: 23791504
[TBL] [Abstract][Full Text] [Related]
28. [Comparation study of incidental irradiation dose to the internal mammary chain during postmastectomy radiotherapy for patients treated with different irradiation techniques].
Wang W; Meng YT; Song YF; Sun T; Xu M; Shao Q; Zhang YJ; Li JB
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):335-340. PubMed ID: 29860759
[No Abstract] [Full Text] [Related]
29. IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC: A direct comparison of PET-based treatment planning.
Fleckenstein J; Kremp K; Kremp S; Palm J; Rübe C
Strahlenther Onkol; 2016 Feb; 192(2):75-82. PubMed ID: 26438071
[TBL] [Abstract][Full Text] [Related]
30. Role of IMRT in reducing penile doses in dose escalation for prostate cancer.
Sethi A; Mohideen N; Leybovich L; Mulhall J
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):970-8. PubMed ID: 12605975
[TBL] [Abstract][Full Text] [Related]
31. Craniospinal irradiation techniques: a dosimetric comparison of proton beams with standard and advanced photon radiotherapy.
Yoon M; Shin DH; Kim J; Kim JW; Kim DW; Park SY; Lee SB; Kim JY; Park HJ; Park BK; Shin SH
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):637-46. PubMed ID: 20932690
[TBL] [Abstract][Full Text] [Related]
32. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
[TBL] [Abstract][Full Text] [Related]
33. An in silico planning study comparing doses and estimated risk of toxicity in 3D-CRT, IMRT and proton beam therapy of patients with thymic tumours.
Lideståhl A; Mondlane G; Gubanski M; Lind PA; Siegbahn A
Phys Med; 2019 Apr; 60():120-126. PubMed ID: 31000071
[TBL] [Abstract][Full Text] [Related]
34. Intensity modulated radiation therapy versus three-dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparison.
MacDonald SM; Ahmad S; Kachris S; Vogds BJ; DeRouen M; Gittleman AE; DeWyngaert K; Vlachaki MT
J Appl Clin Med Phys; 2007 Apr; 8(2):47-60. PubMed ID: 17592465
[TBL] [Abstract][Full Text] [Related]
35. [Internal target volume definition using four-dimensional CT and dosimetric evaluation for hepatocellular carcinoma].
Xi M; Liu MZ; Deng XW; Liu H; Huang XY; Zhang L; Li QQ; Hu YH; Cai L; Cui NJ
Ai Zheng; 2007 Jan; 26(1):1-8. PubMed ID: 17222359
[TBL] [Abstract][Full Text] [Related]
36. Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients.
Deng X; Han C; Chen S; Xie C; Yi J; Zhou Y; Zheng X; Deng Z; Jin X
J Appl Clin Med Phys; 2017 Jan; 18(1):25-31. PubMed ID: 28291936
[TBL] [Abstract][Full Text] [Related]
37. Dose-volume histogram comparison between static 5-field IMRT with 18-MV X-rays and helical tomotherapy with 6-MV X-rays.
Hayashi A; Shibamoto Y; Hattori Y; Tamura T; Iwabuchi M; Otsuka S; Sugie C; Yanagi T
J Radiat Res; 2015 Mar; 56(2):338-45. PubMed ID: 25609741
[TBL] [Abstract][Full Text] [Related]
38. Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: is it better than three dimensional conformal radiotherapy?
De Sanctis V; Bolzan C; D'Arienzo M; Bracci S; Fanelli A; Cox MC; Valeriani M; Osti MF; Minniti G; Chiacchiararelli L; Enrici RM
Radiat Oncol; 2012 Aug; 7():129. PubMed ID: 22857015
[TBL] [Abstract][Full Text] [Related]
39. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study.
Nicolini G; Ghosh-Laskar S; Shrivastava SK; Banerjee S; Chaudhary S; Agarwal JP; Munshi A; Clivio A; Fogliata A; Mancosu P; Vanetti E; Cozzi L
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):553-60. PubMed ID: 22386376
[TBL] [Abstract][Full Text] [Related]
40. Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors.
Thomas E; Chapet O; Kessler ML; Lawrence TS; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):571-8. PubMed ID: 15890602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
